Plus Therapeutics | CYTX - Interest Expense On Debt

Stock Price
6.00
Daily Change
-0.22 -3.54%
Monthly
105.48%
Yearly
-57.42%
Q2 Forecast
5.96

Plus Therapeutics reported $62K in Interest Expense on Debt for its fiscal quarter ending in December of 2023.





Interest Expense On Debt Change Date
Baxter International USD 58M 14M Sep/2025
Cerus USD 2.33M 96K Jun/2024
Dr.Reddys Laboratories INR 944M 37M Dec/2025
Haemonetics USD 7.21M 3.14M Sep/2025
Infinity Pharmaceuticals USD 45K 0 Jun/2023
Northwest Biotherapeutics USD 1.52M 276K Mar/2024
Plus Therapeutics USD 62K 25K Dec/2023
Sanofi EUR 178M 203M Mar/2026
Sun Pharmaceuticals INR 998.6M 250.6M Sep/2025
Teva Pharmaceutical Industries USD 216M 4M Mar/2026